help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 12, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-1157
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/12/4896    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fechner, P. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fechner, P. Y.
Right arrowPubmed/NCBI databases
*Substance via MeSH
*Genetics Home Reference
Hazardous Substances DB
*MENOTROPINS
Medline Plus Health Information
*Turner Syndrome

Submitted on May 30, 2006
Accepted on September 5, 2006

Differences in FSH Secretion Between 45,X Monosomy Turner Syndrome and 45,X/46,XX Mosaicism Are Evident at an Early Age

Patricia Y. Fechner*, Marsha L. Davenport, Rebecca L. Qualy, Judith L. Ross, Daniel F. Gunther, Erica A. Eugster, Carol Huseman, Anthony J. Zagar, Charmian A. Quigley, and on behalf of the Toddler Turner Study Group

Division of Pediatric Endocrinology, Stanford University, Stanford, CA; Division of Pediatric Endocrinology, University of North Carolina at Chapel Hill, NC; US Medical Division (Endocrinology), Lilly Research Laboratories, Indianapolis, IN; Division of Endocrinology, Thomas Jefferson University, Philadelphia, PA; Children's Hospital and Regional Medical Center, University of Washington School of Medicine, Seattle, WA; Division of Pediatric Endocrinology, Riley Hospital for Children, Indiana University, Indianapolis, IN; Children's Mercy Hospital, Kansas City, MO

* To whom correspondence should be addressed. E-mail: pfechner{at}stanford.edu.

Context: Little information exists regarding FSH values in very young girls with Turner syndrome (TS).

Objectives: To evaluate the pattern, natural progression and karyotype-related differences in FSH secretion in young, prepubertal girls with TS.

Study Design: FSH was measured at study entry and annually for 2 yr.

Setting: "Toddler Turner" study conducted at 11 US pediatric endocrine centers.

Study Participants: 88 girls with karyotype-proven TS aged 9 months to 4 yr.

Main Outcome Measures: By-karyotype differences in FSH concentration; age-related changes in FSH.

Results: Mean (±SD) FSH was markedly elevated in the 45,X (n = 56: 68.3 ± 36.0 IU/L) and Other groups (n = 15 [excluding 3 subjects with Y-containing karyotypes]: 52.7 ± 50.8 IU/L) but was minimally elevated in girls with 45,X/46,XX mosaicism (n = 14: 10.1 ± 13.5 IU/L, P < 0.005 both comparisons). Over the 2-year period, FSH declined in the 45,X group (-13.4 IU/L/yr, P < 0.0001). Nonetheless, only 3 of 159 FSH values fell within normal range for age at any time during the 2-year study. FSH decline was similar in the Other group (-14.3 IU/L/yr, P = 0.0032). In contrast, no significant decrease in FSH with age was observed in the 45,X/46,XX group.

Conclusions: In contrast to the original report of FSH concentrations in individuals with TS (Conte FA et al. 1975, J Clin Endocrinol Metab 40:670-674), this study demonstrates distinct differences in patterns of FSH secretion between young girls with monosomy TS, who have persistent elevation of FSH to age 6, and those with 45,X/46,XX mosaicism, whose FSH values suggest retained ovarian function in the majority. These findings have implications for patient management and family counseling.


Key words: FSH concentration • primary gonadal failure • gonadal dysgenesis • 45,X karyotype • 45,X/46,XX mosaic karyotype




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. Davenport, B. J. Crowe, S. H. Travers, K. Rubin, J. L. Ross, P. Y. Fechner, D. F. Gunther, C. Liu, M. E. Geffner, K. Thrailkill, et al.
Growth Hormone Treatment of Early Growth Failure in Toddlers with Turner Syndrome: A Randomized, Controlled, Multicenter Trial
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3406 - 3416.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society